Differential PD-1/LAG-3 expression and immune phenotypes in metastatic sites of breast cancer

BACKGROUND: A dual blockade against the novel immune checkpoint inhibitor lymphocyte activation gene-3 (LAG-3) and programmed cell death protein-1 (PD-1) is currently considered in advanced breast cancer. Nevertheless, PD-1 or LAG-3 expression within distant metastatic breast cancer tissue remains u...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobottka, Bettina, Moch, Holger, Varga, Zsuzsanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792100/
https://www.ncbi.nlm.nih.gov/pubmed/33413541
http://dx.doi.org/10.1186/s13058-020-01380-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792100/
https://www.ncbi.nlm.nih.gov/pubmed/33413541
http://dx.doi.org/10.1186/s13058-020-01380-w

Ejemplares similares